
Many PAD patients fear a heart attack but have never heard of #acutelimbischemia #ALI. The risk is similar to MI and Stroke and the outcomes are poor. Do you talk to your #PAD patients about ALI? #peripheralarterydisease

Cardiology and Vascular Medicine Specialist. Executive Director of CPC Clinical Research. Director of Vascular Research. University of Colorado.

Many PAD patients fear a heart attack but have never heard of #acutelimbischemia #ALI. The risk is similar to MI and Stroke and the outcomes are poor. Do you talk to your #PAD patients about ALI? #peripheralarterydisease

The American Journal of Managed Care, Colorado Prevention Center, & the University of Colorado, present: Institute for Value-Based Medicine, Population Health Lipid Risk Management Forum & Dinner, Chaired by Dr. Marc Bonaca! More info/to register: event.ajmc.com/event/IVBMAug…

Great to meet new colleagues & see old friends @CUAnschutz for final cardiology #Grand Rounds of 2023-24 #majesticWest #RockyMountainWild @cpcresearch #cardiometabolic @MarcBonaca (📸 credit) @kofi_larry #ConnieHess @StephenWaldoMD

What is #JACC about? Listen as Editor-in-Chief Dr. Harlan Krumholz details why JACC is focused on impact 💥 and ensuring the future of cardiovascular health around the globe 🌎 is better than the past. Watch ⬇️ & learn more here: bit.ly/3VTRAh2 @hmkyale

🌟 2023 Impact Factors are in! The #JACCJournals portfolio remains the strongest among the major cardiovascular portfolios of peer reviewed journals. All eligible JACC Journals ranked in the top 18. More: bit.ly/2OvgHq7 #Cardiology

Vascular medicine expert @MarcBonaca gave us his perspective on the new #PAD guidelines ⬇️healio.com/news/cardiology/2…

Our analysis from VOYAGER-PAD trial published in @CircAHA. New data on Rivaroxaban plus Aspirin in PAD+CAD patients undergoing LER. Thanks to EC Members and Co-Authors! #VascularMedicine @MarcBonaca @cpcresearch @CUDeptMedicine @CUCardiology. ahajournals.org/doi/10.1161/…

A weekend well spent discussing plans for preventing and for improving outcomes for patients with CLTI with the top guns in this field @World_fvs @Vascular_India @VascularSVS @ESVSmembership @DGArmstrong @jmills1955 @RMotaganahalli @drvsbedi @RKTvascular

1/ Released today, the 2024 Peripheral Artery Disease Guideline was developed by AHA and @ACCIntouch in collaboration with and endorsed by: @AACVPR @APMA @abcardio1 @SCAI @SVM_tweets @for_svn @VascularSVS @SIRspecialists @VESurgery 📷 The process for multi-society involvement

We just wrapped our final press conference for #ACC24! ✅ A big thank you to discussants Dr. @MarcBonaca, Dr. @jennifer_rymer and @kim_guibone, DNP, for their excellent remarks to close out the press program.

You have found it! Your source for free CE/CME via Twitter! Each program provides 0.5h credit for #physicians, #pharmacists, and #nurses on topics of interest in the cardiometabolic space. Expert authors! See archived programs (and still earn credit) at cardiometabolic-ce.com.




Next stop 🛑 in B309 is Kevin Rogers presenting - Risk of Adverse Events in Peripheral Artery Disease Patients with Below-Knee Disease: An Analysis from the VOYAGER-PAD Catheter-Based Angiographic Core Lab at 8:49 AM ET! 🚂🚃
